| |
| |
|
| Insider
Information: |
Milano Vincent |
| Relationship: |
|
| City: |
Exton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
99,377 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$505,504 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
99,377 |
|
|
| Total
Value |
$505,504 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
4
|
|
Stock
price went up :
|
2
|
1
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
2.0
|
| Percentage
Gain/Loss : |
 9.9%
|
 -141.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Verticalnet Inc |
VERT |
Director |
2008-01-25 |
0 |
2005-01-20 |
0 |
Premium* |
|
|
Viropharma Inc |
VPHM |
President and CEO, Dir... |
2014-01-24 |
0 |
2005-12-13 |
0 |
Premium* |
|
|
Aceragen, Inc |
ACGN |
|
2023-08-10 |
8,987 |
2014-12-12 |
0 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
Director |
2018-06-13 |
10,000 |
2017-06-15 |
0 |
Premium* |
|
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2018-05-31 |
0 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2024-05-31 |
67,867 |
2021-11-24 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
|
2024-06-01 |
12,523 |
2022-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VPHM |
Viropharma Inc |
officerTitle |
• – – |
2005-12-13 |
4 |
S |
$19.82 |
$1,188,994 |
D/D |
(59,999) |
35,698 |
|
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2009-02-27 |
4 |
S |
$4.01 |
$9,569 |
D/D |
(2,300) |
66,367 |
0 |
- |
|
| VPHM |
Viropharma Inc |
President and CEO |
• • – |
2012-11-08 |
4 |
S |
$24.54 |
$2,047,328 |
D/D |
(83,418) |
94,416 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
President & CEO |
• • – |
2020-01-07 |
4 |
S |
$1.78 |
$5,352 |
D/D |
(3,006) |
86,560 |
0 |
% |
|
| ACGN |
Aceragen, Inc |
President & CEO |
• • – |
2021-01-05 |
4 |
S |
$3.91 |
$10,700 |
D/D |
(2,740) |
211,821 |
0 |
% |
|
| ACGN |
Aceragen, Inc |
President & CEO |
• • – |
2021-01-12 |
4 |
S |
$4.20 |
$13,474 |
D/D |
(3,210) |
208,611 |
0 |
% |
|
| ACGN |
Aceragen, Inc |
|
– • – |
2023-08-10 |
4 |
S |
$0.53 |
$1,750 |
D/D |
(3,283) |
8,987 |
0 |
% |
|
57 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
